Epigenetic Alterations in Canine Malignant Lymphoma: Future and Clinical Outcomes
Canine malignant lymphoma is a common neoplasia in dogs, and some studies have used dogs as a research model for molecular mechanisms of lymphomas in humans. In two species, chemotherapy is the treatment of choice, but the resistance to conventional anticancer drugs is frequent. The knowledge of mol...
Main Authors: | Esperanza Montaner-Angoiti, Pablo Jesús Marín-García, Lola Llobat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Animals |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-2615/13/3/468 |
Similar Items
-
Use of genome‐wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high‐grade B‐cell lymphoma
by: Yong Bin Teoh, et al.
Published: (2024-01-01) -
MicroRNAs as Biomarkers in Canine Osteosarcoma: A New Future?
by: Olivia Gourbault, et al.
Published: (2020-09-01) -
Evaluation of Serum YKL-40 in Canine Multicentric Lymphoma: Clinical and Diagnostic Implications
by: Chien-Chun Kuo, et al.
Published: (2024-11-01) -
Impact of local anesthetics on epigenetics in cancer
by: Lucillia Bezu, et al.
Published: (2022-08-01) -
Immunohistochemical Characterization of Tumor-Associated Macrophages in Canine Lymphomas
by: Sergio Vázquez, et al.
Published: (2021-08-01)